Related Experiment Video
Updated: Mar 22, 2026

05:29
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
3.3K
Constraint based temporal event sequence mining for Glioblastoma survival prediction
Kunal Malhotra1, Shamkant B Navathe1, Duen Horng Chau1
1College of Computing, Georgia Institute of Technology, Atlanta, GA, USA.
Journal of Biomedical Informatics
|April 12, 2016
Summary
Predicting Glioblastoma (GBM) survival is key for personalized medicine. This study identifies clinical, genomic, and treatment pattern factors that accurately predict patient survival, aiding in treatment plan development.
Area of Science:
- Oncology
- Bioinformatics
- Medical Informatics
Background:
- Glioblastoma (GBM) is a rare cancer with significant treatment challenges.
- Developing personalized treatment plans for GBM patients is crucial for improving outcomes.
Purpose of the Study:
- To predict which Glioblastoma (GBM) patients will survive longer than the median survival time.
- To assess the predictive power of treatment patterns in conjunction with clinical and genomic factors.
Main Methods:
- Developed a predictive model using clinical and genomic data from approximately 300 newly diagnosed GBM patients.
- Employed sequential mining algorithms with 'exact-order' and 'temporal overlap' constraints to extract treatment patterns.
- Utilized logistic regression and Cox regression models to predict patient survival outcomes.
Main Results:
- Identified key predictive features including gene mRNA expression levels, age, Karnofsky performance score, and prescribed therapeutic agents.
- Achieved a c-statistic of 0.85 with the logistic regression model and 0.84 with the Cox regression model.
- Demonstrated the significant impact of diverse feature sources on survival prediction accuracy.
Conclusions:
- Diverse data sources, including clinical, genomic, and treatment patterns, are vital for predicting GBM patient survival.
- The developed predictive model represents a foundational step towards personalized treatment strategies for GBM.
- The methodology can be extended to other cancer types for broader application in personalized oncology.
Keywords:
ClassificationGlioblastomaGraph miningPredictive modelSequential pattern miningTreatment patternsMore Related Videos
Related Concept Videos
Survival Tree
464
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
464
Introduction To Survival Analysis
935
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
935
Cancer Survival Analysis
820
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
820
Kaplan-Meier Approach
707
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
707
Comparing the Survival Analysis of Two or More Groups
697
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
697

